Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 17, Pages 3907
Publisher
MDPI AG
Online
2021-08-31
DOI
10.3390/jcm10173907
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
- (2021) Arvinder S Soin et al. Lancet Respiratory Medicine
- High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
- (2021) Giuseppe Cappellano et al. EMBO Molecular Medicine
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Early osteopontin levels predict mortality in patients with septic shock
- (2020) Federico Carbone et al. European Journal of Internal Medicine
- Clinical course and mortality risk of severe COVID-19
- (2020) Paul Weiss et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
- (2020) Yingxia Liu et al. National Science Review
- Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
- (2020) Tariq U. Azam et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Relationship between serum osteopontin levels and the severity of COVID-19 infection
- (2020) Ceyhun Varım et al. WIENER KLINISCHE WOCHENSCHRIFT
- The Role of Osteopontin as a Diagnostic and Prognostic Biomarker in Sepsis and Septic Shock
- (2019) Luigi Mario Castello et al. Cells
- Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
- (2018) Sven Loosen et al. Journal of Clinical Medicine
- Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma
- (2017) Sven H. Loosen et al. JOURNAL OF HEPATOLOGY
- Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
- (2017) Nausicaa Clemente et al. Frontiers in Immunology
- Osteopontin levels are elevated in patients with eosinophilic pneumonia
- (2010) Takuya UENO et al. RESPIROLOGY
- Osteopontin: Role in immune regulation and stress responses
- (2008) Kathryn X. Wang et al. CYTOKINE & GROWTH FACTOR REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation